A high-throughput drug screen consisting of 16 000 small molecule inhibitors (Maybridge Chemicals) was completed in synovial sarcoma cell lines expressing the SS18-SSX oncoprotein. The gene discussed is SSX2; the disease is synovial sarcoma.